<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
<!--    <meta content="width=device-width, initial-scale=1.0" name="viewport">-->
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">

</head>

<body>

<div class="uk-container">
    <p> View in chapter -> <a href="5_treatment_of_current_(active)_disease_therapy__c__special_clinical_situations.html/#table13"> Special Clinical Situations </a></p>
    <p>NOTE: Drug adjustments are based on the creatinine clearance (CrCl) which can be estimated as follows:</p>
    <p>[(140-age in yrs)(Ideal body weight in kg) for men (x 0l85 for women)] / [(72) (serum creatinine, mg/dL)]</p>
    <p>Ideal body weight for men: 50 kg + 2.3 kg per inch over 5 feet</p>
    <p>Ideal body weight for women: 45.5 kg + 2.3 kg per inch over 5 feet</p>


    <div class="uk-overflow-auto"
         id="table_13_antituberculosis_antibiotics_in_adult_patients_with_renal_impairment">
        <table class="uk-table uk-table-small uk-table-divider">
            <thead>
            <tr>
                <th>Drug</th>
                <th class="uk-table-expand">Usual Dose (UD) Normal Renal Function</th>
                <th class="uk-text-nowrap">CrCl 30-90</th>
                <th class="uk-table-expand">CrCL <30 or Hemodialysis</th>
                <th class="uk-table-expand">Peritoneal Dialysis</th>
            </tr>
            </thead>
            <tr>
                <td>INH</td>
                <td>300 mg/day</td>
                <td>UD</td>
                <td>UD</td>
                <td rowspan="8">Data currently are not available for patients receiving peritoneal dialysis. Until data
                    become available, begin with doses recommended for patients receiving hemodialysis and verify
                    adequacy of dosing using serum concentration monitoring.
                </td>
            </tr>
            <tr>
                <td>Rifampin</td>
                <td>600 mg/day</td>
                <td>UD</td>
                <td>UD</td>
            </tr>
            <tr>
                <td>Ethambutol</td>
                <td>15-25 mg/kg/day</td>
                <td>UD</td>
                <td>20-25 mg/kg/dose thrice weekly</td>
            </tr>
            <tr>
                <td>Pyrazinamide</td>
                <td>25 mg/kg d (max 2 gm/day)</td>
                <td>UD</td>
                <td>25-35 mg/kg/dose thrice weekly</td>
            </tr>
            <tr>
                <td>Levofloxacin</td>
                <td>750 mg/day</td>
                <td>UD</td>
                <td>750-1000 mg/dose thrice weekly</td>
            </tr>
            <tr>
                <td>Moxifloxacin</td>
                <td>400 mg/day</td>
                <td>UD</td>
                <td>UD</td>
            </tr>
            <tr>
                <td>Amikacin</td>
                <td>15 mg/kg/daily or thrice weekly</td>
                <td>UD</td>
                <td>15 mg/kg/dose thrice weekly</td>
            </tr>
            <tr>
                <td>Linezolid</td>
                <td>600 mg/day</td>
                <td>UD</td>
                <td>UD</td>
            </tr>
        </table>
        <ul class="uk-list uk-list-disc">
            <li>Standard doses are given unless there is intolerance.</li>
            <li>The medications should be given after hemodialysis on the day of hemodialysis.</li>
            <li>Monitoring of serum drug concentrations should be considered to ensure adequate drug absorption, without
                excessive accumulation, and to assist in avoiding toxicity.
            </li>
            <li>In patients with 30–50 mL/min creatinine clearance, standard doses are used by experts, but measurement
                of serum concentrations 2 and 6 hours after timed administration can be used to assist with optimizing
                drug dosages.
            </li>
        </ul>
        <p><a href="https://academic.oup.com/cid/article/63/7/e147/2196792">Based on Nahid et al. Clin Infect Dis
            2016;63(7):e147–95, Table 11</a></p>
    </div>
</div>

</body>

<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
</html>
